Study | First author | Year | Journala | Volume | Pages |
---|---|---|---|---|---|
1 | Aizer | 2009 | Radiother Oncol | 93 | 185–191 |
2 | Alicikus | 2011 | Cancer | 117 | 1429–1437 |
3 | Cahlon | 2008 | IJROBP | 71 | 330–337 |
4 | Eade | 2007 | IJROBP | 68 | 682–689 |
5 | Kuban | 2008 | IJROBP | 70 | 67–74 |
6 | Lukka | 2005 | J Clin Oncol | 23 | 6132–6138 |
7 | Valdagni | 2005 | Radiother Oncol | 75 | 74–82 |
8 | Zelefsky | 2008 | IJROBP | 71 | 1028–1033 |
9 | Miralbell | 2012 | IJROBP | 82 | e17–24 |
10 | Arcangeli | 2012 | IJROBP | 84 | 1172–1178 |
11 | Catton | 2017 | J Clin Oncol | 35 | 1884–1890 |
12 | Dearnaley | 2016 | The Lancet Oncology | 17 | 1047–1060 |
13 | Incrocci | 2016 | The Lancet Oncology | 17 | 1061–1069 |
14 | Kim | 2014 | Radiat Oncol J | 32 | 187–197 |
15 | Kupelian | 2005 | IJROBP | 63 | 1463–1468 |
16 | Leborgne | 2009 | IJROBP | 74 | 1441–1446 |
17 | Leborgne | 2012 | IJROBP | 82 | 1200–1207 |
18 | Pollack | 2013 | J Clin Oncol | 31 | 3860–3868 |
19 | Yeoh | 2006 | IJROBP | 66 | 1072–1083 |
20 | Cheung | 2016 | IJROBP | 96 | S33 |
21 | Di Muzio | 2016 | Clin Oncol (R Coll Radiol) | 28 | 490–500 |
22 | Faria | 2011 | Radiother Oncol | 101 | 486–489 |
23 | Fonteyne | 2012 | IJROBP | 84 | e483–490 |
24 | Hashimoto | 2017 | Int J Clin Oncol | NA | NA |
25 | Kuban | 2010 | IJROBP | 78 | S58–59 |
26 | Kupelian | 2007 | IJROBP | 68 | 1424–1430 |
27 | Lieng | 2017 | Radiother Oncol | 122 | 93–98 |
28 | Livsey | 2003 | IJROBP | 57 | 1254–1259 |
29 | Mai | 2010 | IJROBP | 78 | S59 |
30 | Patel | 2013 | IJROBP | 86 | 534–539 |
31 | Pervez | 2017 | Am J Clin Oncol | 40 | 200–206 |
32 | Shimizu | 2017 | Anticancer Res | 37 | 5829–5835 |
33 | Thomson | 2012 | Prostate Cancer | NA | NA |
34 | Viani | 2016 | Rep Pract Oncol Radiother | 21 | 162–167 |
35 | Bolzicco | 2013 | BMC Urol | 13 | NA |
36 | Fuller | 2014 | Front Oncol | 4 | NA |
37 | Kang | 2011 | Tumori | 97 | 43–48 |
38 | Katz | 2013 | Radiat Oncol | 8 | NA |
39 | King | 2013 | Radiother Oncol | 109 | 217–221 |
40 | Lee | 2014 | Medicine (Baltimore) | 93 | e290 |
41 | Loblaw | 2013 | Radiother Oncol | 107 | 153–158 |
42 | Mantz | 2014 | Front Oncol | 4 | NA |
43 | Meier | 2016 | IJROBP | 96 | S33–34 |
44 | Tsang | 2021 | Radiother Oncol | 158 | 184–190 |
45 | Chin,S | 2020 | IJROBP | 107 | 288–296 |